Crestwood Advisors Lowered Its Medtronic Plc Shs (MDT) Position by $435,520; Stock Declined; Consulta LTD Has Decreased Its Stake in Nike (NKE) as Stock Rose

April 23, 2018 - By Darrin Black

Medtronic plc (NYSE:MDT) Logo

Consulta Ltd decreased its stake in Nike Inc (NKE) by 41.18% based on its latest 2017Q4 regulatory filing with the SEC. Consulta Ltd sold 350,000 shares as the company’s stock rose 4.55% while stock markets declined. The institutional investor held 500,000 shares of the consumer non-durables company at the end of 2017Q4, valued at $31.28M, down from 850,000 at the end of the previous reported quarter. Consulta Ltd who had been investing in Nike Inc for a number of months, seems to be less bullish one the $107.79B market cap company. The stock increased 1.19% or $0.785 during the last trading session, reaching $66.875. About 4.91 million shares traded. NIKE, Inc. (NYSE:NKE) has risen 18.31% since April 23, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.

Crestwood Advisors Llc decreased its stake in Medtronic Plc Shs (MDT) by 2.16% based on its latest 2017Q4 regulatory filing with the SEC. Crestwood Advisors Llc sold 5,444 shares as the company’s stock declined 4.15% with the market. The institutional investor held 246,551 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $19.91 million, down from 251,995 at the end of the previous reported quarter. Crestwood Advisors Llc who had been investing in Medtronic Plc Shs for a number of months, seems to be less bullish one the $108.48 billion market cap company. The stock increased 0.17% or $0.135 during the last trading session, reaching $80.035. About 1.89 million shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since April 23, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Since December 11, 2017, it had 0 insider purchases, and 8 selling transactions for $45.81 million activity. Slusher John F sold $4.75M worth of NIKE, Inc. (NYSE:NKE) on Friday, January 5. $6.77M worth of NIKE, Inc. (NYSE:NKE) was sold by SPRUNK ERIC D on Monday, January 29. Matheson Monique S. sold $650,000 worth of stock. PARKER MARK G sold $8.78 million worth of stock.

Among 44 analysts covering Nike Inc. (NYSE:NKE), 25 have Buy rating, 2 Sell and 17 Hold. Therefore 57% are positive. Nike Inc. had 233 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Oppenheimer given on Wednesday, January 31. Buckingham Research maintained NIKE, Inc. (NYSE:NKE) on Tuesday, October 17 with “Buy” rating. The firm has “Buy” rating given on Wednesday, March 23 by Jefferies. The firm has “Buy” rating by Argus Research given on Tuesday, September 29. As per Monday, October 31, the company rating was downgraded by Bank of America. Credit Suisse initiated NIKE, Inc. (NYSE:NKE) rating on Thursday, March 22. Credit Suisse has “Buy” rating and $7800 target. The company was maintained on Tuesday, September 19 by Jefferies. The firm has “Buy” rating by Goldman Sachs given on Wednesday, June 29. The company was maintained on Tuesday, December 26 by DA Davidson. Piper Jaffray maintained NIKE, Inc. (NYSE:NKE) on Thursday, March 23 with “Neutral” rating.

Analysts await NIKE, Inc. (NYSE:NKE) to report earnings on July, 5. They expect $0.64 earnings per share, up 6.67% or $0.04 from last year’s $0.6 per share. NKE’s profit will be $1.03 billion for 26.12 P/E if the $0.64 EPS becomes a reality. After $0.68 actual earnings per share reported by NIKE, Inc. for the previous quarter, Wall Street now forecasts -5.88% negative EPS growth.

Consulta Ltd, which manages about $846.53 million US Long portfolio, upped its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 75,000 shares to 250,000 shares, valued at $47.47 million in 2017Q4, according to the filing.

Investors sentiment decreased to 0.74 in 2017 Q4. Its down 0.06, from 0.8 in 2017Q3. It worsened, as 70 investors sold NKE shares while 501 reduced holdings. 109 funds opened positions while 312 raised stakes. 1.01 billion shares or 2.95% more from 985.62 million shares in 2017Q3 were reported. Park Circle reported 800 shares. First State Bank Of Hutchinson reported 7,790 shares. Bryn Mawr Co accumulated 273,817 shares. Bokf Na stated it has 112,087 shares. Moreover, Conestoga Cap Advisors Ltd Liability Co has 0.01% invested in NIKE, Inc. (NYSE:NKE). Obermeyer Wood Investment Counsel Lllp reported 502,900 shares. Advisory Ltd Com stated it has 15,990 shares or 0.09% of all its holdings. Fiduciary Trust has invested 0.42% in NIKE, Inc. (NYSE:NKE). Alpine Glob Limited Liability reported 14,906 shares. Valley Natl Advisers Inc reported 0.02% of its portfolio in NIKE, Inc. (NYSE:NKE). Riverhead Mngmt Ltd Limited Liability Company reported 0.06% in NIKE, Inc. (NYSE:NKE). Moreover, Ashfield Capital Ptnrs Ltd Liability has 0.49% invested in NIKE, Inc. (NYSE:NKE) for 61,060 shares. 112 are held by Atwood & Palmer. Winslow Evans And Crocker has 7,320 shares. Parametrica Management Limited has invested 0.17% in NIKE, Inc. (NYSE:NKE).

Crestwood Advisors Llc, which manages about $1.20B and $1.26 billion US Long portfolio, upped its stake in Home Depot Inc Com (NYSE:HD) by 1,825 shares to 3,269 shares, valued at $619,000 in 2017Q4, according to the filing. It also increased its holding in Fortive Corp Com by 6,259 shares in the quarter, for a total of 225,740 shares, and has risen its stake in Eog Res Inc Com (NYSE:EOG).

Analysts await Medtronic plc (NYSE:MDT) to report earnings on May, 24. They expect $1.38 EPS, up 3.76% or $0.05 from last year’s $1.33 per share. MDT’s profit will be $1.87B for 14.50 P/E if the $1.38 EPS becomes a reality. After $1.17 actual EPS reported by Medtronic plc for the previous quarter, Wall Street now forecasts 17.95% EPS growth.

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 82 analyst reports since August 10, 2015 according to SRatingsIntel. The stock has “Buy” rating by UBS on Friday, February 17. The company was maintained on Wednesday, April 19 by RBC Capital Markets. SunTrust maintained Medtronic plc (NYSE:MDT) rating on Monday, June 13. SunTrust has “Buy” rating and $98 target. The rating was maintained by BMO Capital Markets on Tuesday, December 12 with “Buy”. The firm has “Buy” rating by RBC Capital Markets given on Friday, September 22. BMO Capital Markets maintained Medtronic plc (NYSE:MDT) on Wednesday, November 23 with “Outperform” rating. The firm has “Buy” rating by UBS given on Friday, August 26. BMO Capital Markets maintained it with “Buy” rating and $92.0 target in Friday, September 29 report. The company was maintained on Wednesday, September 27 by Cowen & Co. The rating was maintained by Oppenheimer with “Buy” on Friday, May 26.

NIKE, Inc. (NYSE:NKE) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>